ICD-10-CM 2027
ICD-10 code for Hyperheparinemia
Hemorrhagic disorder due to extrinsic circulating anticoagulants
From the official ICD-10-CM alphabetic index entry “Hyperheparinemia”. Page updated September 29, 2026.
About coding Hyperheparinemia
The ICD-10-CM code for Hyperheparinemia is D68.32 (Hemorrhagic disorder due to extrinsic circulating anticoagulants).
Within D68.3 (hemorrhagic disorder due to circulating anticoagulants), D68.32 is specifically for hemorrhagic disorder due to extrinsic circulating anticoagulants. Related codes cover intrinsic circulating anticoagulants, antibodies, or inhibitors (D68.31).
Use an additional code for adverse effect, if applicable, to identify drug (T45.515, T45.525).
As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.
Common questions about Hyperheparinemia ICD-10 codes
What is the ICD-10 code for Hyperheparinemia?
- D68.32 — Hemorrhagic disorder due to extrinsic circulating anticoagulants.
Is D68.32 billable?
- Yes. D68.32 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can D68.32 be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict D68.32 as a principal diagnosis.
Is D68.32 a CC or MCC?
- D68.32 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.